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Abstract 
Nanotechnology is unique in that it represents not just one specific area, but a vast variety of disciplines ranging 
from basic material science to personal care applications. Thus this technology is very advanced and various 
researches are a heading in this field very quickly One of the important areas of nanotechnology is “nanomedicine,” 
which, refers to highly specific medical intervention at the molecular scale for diagnosis, prevention and treatment 
of diseases. The importance of nanotechnology in drug delivery is in the concept and ability to manipulate 
molecules and super molecular structures for producing devices with programmed functions. Conventional 
liposomes, polymeric micelles, and nanoparticles are now called “nanovehicles,”. Those conventional drug 
delivery systems would have evolved to the present state regardless of the current nanotechnology revolution. To 
achieve efficient drug delivery it is important to understand the interactions of nanomaterials with the biological 
environment, targeting cell-surface receptors, drug release, and molecular mechanisms of cell signalling involved 
in pathobiology of the disease under consideration. Several anti-cancer drugs including paclitaxel, doxorubicin, 5-
fluorouracil and dexamethasone have been successfully formulated using nanomaterials. The nano drug delivery 
systems hold great potential to overcome some of the barriers of cells and molecules in heart attack and cancer.  
Keywords: Nanotechnology, nanomedicine, nanoparticles, liposomes, polymeric micelles, nanoparticles, 
dendrimers, and nanocrystals. Liposomes and polymer micelles, PLGA, etc,. 
DOI: 10.7176/APTA/80-03 
Publication date:October 31st 2019 
 
1.INTRODUCTION 
Living organisms contain many molecules which interact with nanoparticles. Most often, nanomaterials will 
become coated with protein molecules. This “corona” of proteins is a shifting population of different molecules. 
Key factors in the interaction with living structures include nanoparticle dose, the ability of nanoparticles to spread 
within the body, as well as their solubility. Some nanoparticles dissolve easily and their effects on living organisms 
are the same as the effects of the chemiotheraphy. 
The reason why these nanoparticles are attractive for medical purposes is based on their important and unique 
features, such as their surface to mass ratio that is much larger than that of other particles, their quantum properties 
and their ability to adsorb and carry other compounds. nanoparticles have a relatively large functional surface 
which is able to bind, adsorb and carry other compounds such as drugs, probes and proteins. However, many 
challenges must be overcome if the application of nanotechnology is to realize the anticipated improved 
understanding of the patho-physiological basis of disease, bring more sophisticated diagnostic opportunities, and 
yield improved therapies. Nanoparticles hold tremendous potential as an effective drug delivery system. To 
achieve efficient drug delivery it is important to understand the interactions of nanomaterials with the biological 
environment, targeting cell-surface receptors, drug release, and molecular mechanisms of cell signalling involved 
in pathobiology of the disease under consideration. Several anti-cancer drugs including paclitaxel, doxorubicin, 5-
fluorouracil and dexamethasone have been successfully formulated using nanomaterials. Quantom dots, chitosan, 
Polylactic/glycolic acid (PLGA) based nanoparticles have been used Anti-cancer drugs . Brain cancer is one of the 
most difficult malignancies to detect and treat mainly because of the difficulty in getting imaging and therapeutic 
agents past the blood-brain barrier and into the brain. Anti-cancer drugs such as loperamide and doxorubicin bound 
to nanomaterials and released at therapeutic concentrations in the brain.  
 
2.Preparation of  Nanoparticles through ionic gelation method  
Nanoparticles can be prepared from a variety of materials such as proteins, polysaccharides and  synthetic polymers. 
The selection of matrix  materials is dependent on many factors including (a) size of nanoparticles required; (b) 
inherent properties of the drug and stability; (c) surface characteristics such as charge  and permeability; (d) degree 
of biodegradability and toxicity and (f) Antigenicity of the final product. Nanoparticles have been prepared most 
frequency by three methods: (1) dispersion of preformed polymers; (2) polymerization of monomers; and (3) ionic 
gelation or coacervation of hydrophilic polymers. Here, the ionic gelation method has been focused on the  
preparation of nanoparticles using biodegradable hydrophilic polymers such as chitosan, gelatin and sodium 
alginate. The method involves a mixture of two aqueous  phases, of which one is the polymer chitosan, a  di-block 
co-polymer ethylene oxide or propylene  oxide (PEO-PPO) and the other is a polyanion  sodium tripolyphosphate. 
In this method,  positively charged amino group of chitosan  interacts with negative charged tripolyphosphate  to 
Advances in Physics Theories and Applications                                                                                                  www.iiste.org 
ISSN 2224-719X (Paper) ISSN 2225-0638 (Online) 
Vol.80, 2019         
 
15 
 
form coacervates with a size in the range of  nanometer. Coacervates are formed as  a result  of electrostatic 
interaction between two aqueous  phases, whereas, ionic gelation involves the  material undergoing transition from 
liquid to gel due to ionic interaction conditions at room  temperature. 
 
3.DISCUSSION 
3.1 Interaction of nanoparticles with human cancer cell. 
Cancer is one of the most challenging diseases today, and brain cancer is one of the most difficult malignancies to 
detect and treat mainly because of the difficulty in getting imaging and therapeutic agents across the blood-brain 
barrier and into the brain. Apolipoprotein E was suggested to mediate drug transport across the blood-brain barrier  
Loperamide, which does not cross the blood-brain barrier but exerts antinociceptive effects after direct injection 
into the brain, was loaded into human serum.  
Nanoshells may be used to concentrate the heat from infrared light to kill cancer cells with minimal damage 
to surrounding healthy body cells. A nanoshell consists of a gold coated metal shell and a non-conducting silica 
centre and the shell is able to absorb nearby infrared laser energy emitted by a source. The nanoparticles are 
injected into the bloodstream where they travel to the cancerous growth.  The advantage of using nanoshells to 
treat cancerous tumours is that they can destroy cancerous cells but do not excessively damage normal cells in the 
process (see Figure 2).There is an advantage over chemotherapy, which destroys both cancerous and normal cells. 
The drugs used in chemotherapy are not able to target the cancerous growth specifically, and the damage of healthy 
body cells can result in secondary conditions such as immune system suppression and hair loss, whereas 
nanoparticles have the potential to be able to target only the cancer cells, so prove to be a more harmless treatment.  
Quantum Dots may be used in the future for locating cancer tumours in patients. where the quantum dots 
have been observed to give off a detectable fluorescence when stimulated by UV light, hence indicating the 
position of the tumour. By combining different sized quantum dots within individual granules, granules that release 
distinctive colours and intensities of light, after stimulation by UV light, can be created. The large variety of 
quantum dots can give scientists the potential to make them into many different granules so high numbers of DNA 
sections can be coded for and recognized. Cancerous tumours contain many different types of mutating DNA, so 
therefore quantum dots can be used to identify different kinds of cancer, reducing the requirement for an invasive 
biopsy which can be uncomfortable for the patient. Quantum dots are highly resilient against photo bleaching and 
come in a diverse range of colour shades allowing a great range of cells to be identified .The quantum dots also 
have high contrast which makes them able to recognize the smallest of tumours, allowing early detection. 
Using superparamagnetic iron oxide nanoparticles in order to increase the visual distinction between cancer 
and normal brain tissue. The nanoprobe is made of up an iron oxide core, coated with PEG (polyethylene glycol), 
and joined together with the targeting agent chlorotoxin. Chlorotoxin is a scorpion derived 36 amino acid peptide, 
which has high selectivity for gliomas and other brain cancers, once it has been injected into the bloodstream. It 
has also been show to be able to bind to medullablastoma , prostatecancer and intestinal cancer. Non targeting 
nanoparticles are those which do not contain agents which are able to specifically target and bind to the cancer 
cells, but chlorotoxin is able to bind to cancer cells . This gives the potential to lead on to significant improvements 
in cancer detection and localization by exploitation of the unique molecular build up of cancer cells. 
There is a type of protein called laminin-411 that plays amajor part in the tumour’s tendency to create new 
blood vessels to aid its growth and development and metastasis. The ability of technology to block this protein 
could lead to an advance in glioma treatment. The single cell organism Physarum polycephalum. It was created 
with the specific property of being able to permeate the tumour cells, and enter the endosomes. As endosomes 
mature, they become acidic and the chemical constituent of the drug is able to act at this point and break the 
endosomes’ membranes. The tumour cells’ production of laminin-411 is able to be blocked, preventing the protein 
from being formed  and production of new tumour vessels. The drug is able to enter the brain and target the cancer 
specifically. Due to its strong chemical bonds, the components of the drug are able to avoid damage or separation 
in tissues or blood plasma during their transport through the human system. The anti tumour component is able to 
activate directly inside tumour cells, which is different from other nanomedicine drugs that activate at the site of 
tumour, not in the tumour cells themselves. When the nanobioconjugate has accomplished its tasks, the body 
digests it completely, leaving no harmful residue. It is changed into carbon dioxide and water which is not toxic 
to healthy cells. Another advantage is that doesn’t stimulate the immune system to produce reactions such as 
coughs or rashes or any other systems.  
 
3.2 Interaction of nanoparticles with Collalegen to cure Heart attack 
According to the invention there is provided a synthetic collagen-like material comprising chains of repeating 
trimeric amino acid building blocks, in which about 30% of the amino acids are glycine, and at least about 10% 
are proline orhydroxyproline, the improvement comprising the incorporation, at least in part, of peptoid residues 
in said repeating trimeric building blocks and formation of a peptoid residue-containing triple helix from the chains 
assembled from those peptoid residuecontaining building blocks. invention the synthetic collagen material 
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comprises chains of repeating building blocks which are either tripeptide sequences, trimeric dipeptide-peptoid 
residue sequences or peptide-peptoidresidue-peptide sequences selected from the group consisting of Gly-Xp-Pro; 
Gly-Pro-Yp; Gly-Pro-Hyp; and Gly-Pro-Pro; or combinations thereof, wherein Xp and Yp are peptoid residues, 
and the chains have a triple helix conformation similar to that of collagen. In a particularly preferred embodiment, 
the synthetic collagen material comprises amino acid chains made up of repeating trimeric building blocks selected 
from the group consisting of Gly-Xp-Pro and Gly-Pro-Yp; or combinations thereof. 
 
4.CONCLUSION 
It appears that nano drug delivery systems hold great potential to overcome some of the barriers to efficient 
targeting of cells and molecules in heart valves and cancer. The ability of nanoparticles to specifically target 
cancerous brain tumors and defective valves of hearts gives a promising possibility of minimising damage to 
healthy body cells, which is a disadvantage of some current treatment methods such as chemotherapy resulting in 
a great physical and emotional impact on the patient receiving treatment. Furthermore, the future remains exciting 
and wide open.  
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Fig.1     Collalegen                                               Fig.2    Nanoparticles through ionic gelation 
 
 
  
